47 studies found for:    " January 23, 2008":" February 22, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy
Conditions: Lipodystrophy;   HIV Infections
Interventions: Drug: Tesamorelin;   Drug: Placebo for Tesamorelin
2 Terminated Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: EnvDNA, PolyEnv1, EnvPro
3 Completed
Has Results
FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women
Condition: HIV Infections
Interventions: Drug: Truvada;   Other: Placebo
4 Unknown  Effectiveness of a Cell Phone-Based Program for Abstinence and HIV Risk Prevention
Condition: HIV Infections
Interventions: Behavioral: HIV-related text messaging;   Behavioral: Nutrition-related text messaging
5 Completed Evaluation of the Extension at Community Level of Safe Male Circumcision (ANRS 12126 ORANGE FARM 2)
Condition: HIV Infections
Intervention: Procedure: Male Circumcision
6 Unknown  Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Lumefantrine-artemether and nevirapine;   Drug: lumefantrine-artemether and efavirenz;   Drug: Lumefantrine-artemether and rifampicin
7 Unknown  Early Versus Delayed Routine HIV Testing in Connecticut Jails
Condition: HIV Infections
Intervention: Other: routine HIV testing
8 Terminated
Has Results
MK-0518 Intensification And HDAC Inhibition In Depletion Of Resting CD4+ T Cell HIV Infection
Condition: HIV Infections
Intervention: Drug: Raltegravir; valproic acid
9 Active, not recruiting Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults
Condition: HIV Infections
Intervention: Biological: Ad26.ENVA.01 HIV-1 vaccine
10 Completed Reducing HIV: Safer Sex Skill Building in Pregnant Drug Abusing Women
Conditions: HIV Infections;   Substance Use
Intervention: Behavioral: Safer Sex Skills Building (SSB)
11 Completed A Phase I Pharmacokinetics and Safety Study of Two Dapivirine Intravaginal Gels
Condition: HIV Infections
Interventions: Drug: Dapivirine Gel 4750, 0.05%, 2.5g;   Drug: Dapivirine Gel 4789, 0.05%, 2.5g;   Drug: HEC-based Placebo Gel
12 Completed Effect of Vicriviroc on HIV Ribonucleic Acid (RNA) Levels in Cerebrospinal Fluid (Study P05241)
Condition: HIV Infections
Intervention: Drug: Vicriviroc
13 Completed Naïve HIV POC Monotherapy Trial
Condition: HIV Infections
Interventions: Drug: RDEA806 400 mg;   Drug: Placebo;   Drug: RDEA806 1000 mg;   Drug: RDEA806 600 mg;   Drug: RDEA806 800 mg
14 Completed Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting
Conditions: HIV Infections;   Streptococcus Pneumoniae
Interventions: Biological: pneumococcal conjugate vaccine;   Biological: pneumococcal polysaccharide vaccine
15 Completed Drug Interaction Study Between Lumefantrine and Lopinavir/Ritonavir
Condition: HIV Infections
Interventions: Drug: Lumefantrine - lopinavir/ritonavir drug interaction;   Drug: Lumefantrine only arm
16 Completed
Has Results
PRO 140 by IV Administration in Adults With HIV-1 Infection
Condition: HIV Infections
Interventions: Drug: PRO 140;   Drug: Placebo
17 Completed Pharmacokinetics of Rifabutin Combined With Antiretroviral Therapy in Patients With TB/HIV Co-infection in South Africa
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: rifabutin in combination with efavirenz;   Drug: rifabutin in combination with nevirapine;   Drug: rifabutin in combination with lopinavir/ritonavir
18 Completed ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Condition: HIV Infections
Interventions: Drug: Atripla;   Drug: Kivexa plus Sustiva
19 Completed Clinical Trial of CNS-targeted HAART (CIT2)
Condition: HIV Infections
Intervention: Drug: FDA Approved Antiretroviral Therapy (see list below)
20 Terminated Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection
Condition: HIV Infections
Interventions: Drug: apricitabine;   Drug: lamivudine

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years